Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine
- PMID: 35065856
- PMCID: PMC8554006
- DOI: 10.1016/j.jemermed.2021.10.038
Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine
Comment on
-
Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.J Emerg Med. 2021 Dec;61(6):e141-e145. doi: 10.1016/j.jemermed.2021.07.062. Epub 2021 Aug 7. J Emerg Med. 2021. PMID: 34538679 Free PMC article.
References
-
- Abrams RMC, Elder GA. Safety of therapeutic plasma exchange for the treatment of Guillain-Barre syndrome in polycythemia vera. Neurologist. 2018;23:185–187. - PubMed
-
- Goldberg K, Wirth FH, Hathaway WE, et al. Neonatal hyperviscosity. II. Effect of partial plasma exchange transfusion. Pediatrics. 1982;69:419–425. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical